Brandes Investment Partners, LP Bausch Health Companies Inc. Transaction History

Brandes Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $28,070 - $56,448	6,129 Added 11.23%	60,698 $418,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $23.63 $108,349 - $362,649	15,347 Added 39.13%	54,569 $456,000
Q1 2022 May 10, 2022	BUY	$21.6 - $27.79 $258,876 - $333,063	11,985 Added 44.0%	39,222 $896,000
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $203,987 - $257,289	8,869 Added 48.29%	27,237 $752,000
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $185,496 - $222,684	7,408 Added 67.59%	18,368 $512,000
Q2 2021 Aug 11, 2021	BUY	$27.43 - $32.7 $300,632 - $358,392	10,960 New	10,960 $321,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Brandes Investment Partners, LP with notifications on news.